Insights

Loading spinner
Gathering insights about Sangamo Therapeutics France

Sangamo Therapeutics France Tech Stack

Sangamo Therapeutics France uses 8 technology products and services including Hotjar, Amazon Web Services, Concrete CMS, and more. Explore Sangamo Therapeutics France's tech stack below.

  • Hotjar
    Analytics
  • Amazon Web Services
    Cloud Hosting
  • Concrete CMS
    Content Management System
  • Okta
    Identity Verification
  • DXC
    Infrastructure As A Service
  • script.aculo.us
    Javascript Libraries
  • Adobe Acrobat DC
    Rich Text Editors
  • HSTS
    Security

Media & News

Sangamo Therapeutics France's Email Address Formats

Sangamo Therapeutics France uses at least 1 format(s):
Sangamo Therapeutics France Email FormatsExamplePercentage
FLast@sangamo.comJDoe@sangamo.com
92%
LastFi@sangamo.comDoeJo@sangamo.com
5%
First@sangamo.comJohn@sangamo.com
2%
FMiddleLast@sangamo.comJMichaelDoe@sangamo.com
1%

Frequently Asked Questions

Where is Sangamo Therapeutics France's headquarters located?

Minus sign iconPlus sign icon
Sangamo Therapeutics France's main headquarters is located at Allée de la Nertière Les Cardoulines Ht1 Les Herbiers, Pays de la Loire France. The company has employees across 1 continents, including Europe.

What is Sangamo Therapeutics France's official website and social media links?

Minus sign iconPlus sign icon
Sangamo Therapeutics France's official website is sangamo.com and has social profiles on LinkedIn.

How much revenue does Sangamo Therapeutics France generate?

Minus sign iconPlus sign icon
As of February 2026, Sangamo Therapeutics France's annual revenue is estimated to be $40M.

What is Sangamo Therapeutics France's SIC code NAICS code?

Minus sign iconPlus sign icon
Sangamo Therapeutics France's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Sangamo Therapeutics France have currently?

Minus sign iconPlus sign icon
As of February 2026, Sangamo Therapeutics France has approximately 9 employees across 1 continents, including Europe. Key team members include Ingénieur: I. M.Accounting Associate: K. E.Research Associate Iii: S. D. L. F. D. -. B.. Explore Sangamo Therapeutics France's employee directory with LeadIQ.

What industry does Sangamo Therapeutics France belong to?

Minus sign iconPlus sign icon
Sangamo Therapeutics France operates in the Biotechnology Research industry.

What technology does Sangamo Therapeutics France use?

Minus sign iconPlus sign icon
Sangamo Therapeutics France's tech stack includes HotjarAmazon Web ServicesConcrete CMSOktaDXCscript.aculo.usAdobe Acrobat DCHSTS.

What is Sangamo Therapeutics France's email format?

Minus sign iconPlus sign icon
Sangamo Therapeutics France's email format typically follows the pattern of FLast@sangamo.com. Find more Sangamo Therapeutics France email formats with LeadIQ.

How much funding has Sangamo Therapeutics France raised to date?

Minus sign iconPlus sign icon
As of February 2026, Sangamo Therapeutics France has raised $1.8B in funding. The last funding round occurred on May 08, 2020 for $225M.

When was Sangamo Therapeutics France founded?

Minus sign iconPlus sign icon
Sangamo Therapeutics France was founded in 1995.

Sangamo Therapeutics France

Biotechnology ResearchPays de la Loire, France2-10 Employees

Sangamo Therapeutics France is the French subsidiary of Sangamo Therapeutics Inc. 

Sangamo Therapeutics, Inc. is focused on translating ground-breaking science into genomic medicines with the potential to transform patients' lives using gene therapy, ex vivo gene-edited cell therapy, in vivo genome editing, and gene regulation. For more information about Sangamo, visit www.sangamo.com.

Sangamo Therapeutics France was formerly TxCell and was acquired by Sangamo Q4 2018.

Section iconCompany Overview

Headquarters
Allée de la Nertière Les Cardoulines Ht1 Les Herbiers, Pays de la Loire France
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1995
Employees
2-10

Section iconFunding & Financials

  • $1.8B

    Sangamo Therapeutics France has raised a total of $1.8B of funding over 2 rounds. Their latest funding round was raised on May 08, 2020 in the amount of $225Mas a funds.

  • $1M

    Sangamo Therapeutics France's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1.8B

    Sangamo Therapeutics France has raised a total of $1.8B of funding over 2 rounds. Their latest funding round was raised on May 08, 2020 in the amount of $225Mas a funds.

  • $1M

    Sangamo Therapeutics France's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.